Comparable radiation sensitivity in p53 wild-type and p53 deficient tumor cells associated with different cell death modalities

被引:10
|
作者
Li, Ping [1 ,2 ,3 ,4 ]
Liu, Xiongxiong [1 ,2 ,3 ,4 ]
Zhao, Ting [1 ,2 ,3 ,4 ]
Li, Feifei [5 ]
Wang, Qiqi [5 ]
Zhang, Pengcheng [1 ,2 ,3 ,4 ]
Hirayama, Ryoichi [6 ]
Chen, Weiqiang [1 ,2 ,3 ,4 ]
Jin, Xiaodong [1 ,2 ,3 ,4 ]
Zheng, Xiaogang [1 ,2 ,3 ,4 ]
Wang, Zhen [7 ]
Li, Qiang [1 ,2 ,3 ,4 ]
机构
[1] Chinese Acad Sci, Inst Modern Phys, Lanzhou, Peoples R China
[2] Chinese Acad Sci, Key Lab Heavy Ion Radiat Biol & Med, Lanzhou, Peoples R China
[3] Key Lab Basic Res Heavy Ion Radiat Applicat Med, Lanzhou, Gansu, Peoples R China
[4] Univ Chinese Acad Sci, Beijing, Peoples R China
[5] Northwest Normal Univ, Coll Life Sci, Lanzhou, Peoples R China
[6] Natl Inst Quantum & Radiol Sci & Technol QST, Inst Quantum Med Sci iQMS, Dept Charged Particle Therapy Res, Chiba, Japan
[7] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Biotechnol, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
SENESCENCE; CHECKPOINT; APOPTOSIS; CANCER; MITOCHONDRIA; MAINTENANCE; IRRADIATION; INHIBITION; SURVIVAL; ARREST;
D O I
10.1038/s41420-021-00570-5
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Studies of radiation interaction with tumor cells often take apoptosis as the desired results. However, mitotic catastrophe and senescence are also promoted by clinically relevant doses of radiation. Furthermore, p53 is a well-known transcription factor that is closely associated with radiosensitivity and radiation-induced cell death. Therefore, we aimed to investigate the involvement of radiosensitivity, cell death modalities and p53 status in response to carbon-ion radiation (CIR) here. Isogenic human colorectal cancer cell lines HCT116 (p53(+/+) and p53(-/-)) were irradiated with high-LET carbon ions. Cell survival was determined by the standard colony-forming assay. 53BP1 foci were visualized to identify the repair kinetics of DNA double-strand breaks (DSBs). Cellular senescence was measured by SA-beta-Gal and Ki67 staining. Mitotic catastrophe was determined with DAPI staining. Comparable radiosensitivities of p53(+/+) and p53(-)(/-) HCT116 colorectal cells induced by CIR were demonstrated, as well as persistent 53BP1 foci indicated DNA repair deficiency in both cell lines. Different degree of premature senescence in isogenic HCT116 colorectal cancer cells suggested that CIR-induced premature senescence was more dependent on p21 but not p53. Sustained upregulation of p21 played multifunctional roles in senescence enhancement and apoptosis inhibition in p53(+/+) cells. p21 inhibition further increased radiosensitivity of p53(+/+) cells. Complex cell death modalities rather than single cell death were induced in both p53(+/+) and p53(-)(/-) cells after 5 Gy CIR. Mitotic catastrophe was predominant in p53(-)(/-) cells due to inefficient activation of Chk1 and Chk2 phosphorylation in combination with p53 null. Senescence was the major cell death mechanism in p53(+/+) cells via p21-dependent pathway. Taken together, p21-mediated premature senescence might be used by tumor cells to escape from CIR-induced cytotoxicity, at least for a time.
引用
收藏
页数:8
相关论文
共 50 条
  • [11] Flavonoids activate wild-type p53
    Plaumann, B
    Fritsche, M
    Rimpler, H
    Brandner, G
    Hess, RD
    ONCOGENE, 1996, 13 (08) : 1605 - 1614
  • [12] Ninjurin 2, a Cell Adhesion Molecule and a Target of p53, Modulates Wild-Type p53 in Growth Suppression and Mutant p53 in Growth Promotion
    Zhang, Jin
    Kong, Xiangmudong
    Yang, Hee Jung
    Mohibi, Shakur
    Lucchesi, Christopher August
    Zhang, Weici
    Chen, Xinbin
    CANCERS, 2024, 16 (01)
  • [13] FUCAI is induced by wild-type p53 and expressed at different levels in thyroid cancers depending on p53 status
    Tsuchida, Nobuo
    Ikeda, Masa-Aki
    Ishino, Yoshizumu
    Grieco, Michele
    Vecchio, Giancarlo
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 50 (06) : 2043 - 2048
  • [14] Therapeutic potential of recombinant p53 overexpression in breast cancer cells expressing endogenous wild-type p53
    Li, PX
    Bui, T
    Gray, D
    Klamut, HJ
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 48 (03) : 273 - 286
  • [15] Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53
    John, LSS
    Sauter, ER
    Herlyn, M
    Litwin, S
    Adler-Storthz, K
    CANCER GENE THERAPY, 2000, 7 (05) : 749 - 756
  • [16] Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53
    Lisa S St. John
    Edward R Sauter
    Meenhard Herlyn
    Samuel Litwin
    Karen Adler-Storthz
    Cancer Gene Therapy, 2000, 7 : 749 - 756
  • [17] Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatment
    Atencio, IA
    Avanzini, JB
    Johnson, D
    Neuteboom, S
    Vaillancourt, MT
    Nielsen, LL
    Hajian, G
    Sutjipto, S
    Sugarman, BJ
    Philopena, J
    McAllister, DL
    Beltran, JC
    Nodelman, M
    Ramachandra, M
    Wills, KN
    MOLECULAR THERAPY, 2001, 4 (01) : 5 - 12
  • [18] Therapeutic potential of recombinant p53 overexpression in breast cancer cells expressing endogenous wild-type p53
    Peixiang Li
    Thuy Bui
    Dawn Gray
    Henry J. Klamut
    Breast Cancer Research and Treatment, 1998, 48 : 273 - 286
  • [19] The Inhibition of Autophagy Sensitises Colon Cancer Cells with Wild-Type p53 but Not Mutant p53 to Topotecan Treatment
    Li, Dan-Dan
    Sun, Ting
    Wu, Xiao-Qi
    Chen, Shu-Peng
    Deng, Rong
    Jiang, Shan
    Feng, Gong-Kan
    Pan, Jing-Xuan
    Zhang, Xiao-Shi
    Zeng, Yi-Xin
    Zhu, Xiao-Feng
    PLOS ONE, 2012, 7 (09):
  • [20] Wild-type p53 in cancer cells: When a guardian turns into a blackguard
    Kim, Ella
    Giese, Alf
    Deppert, Wolfgang
    BIOCHEMICAL PHARMACOLOGY, 2009, 77 (01) : 11 - 20